Synergy Pharmaceuticals
Synergy Pharmaceuticals Inc.
420 Lexington Ave #2012,
New York, NY 10170
Phone: (212) 297-0020
Latest news
- Synergy Pharmaceuticals Announces FDA Approval of Trulance (plecanatide) for the Treatment of Irritable Bowel Syndrome with Constipation (IBS-C) in Adults
25 January 2018 - FDA Approves Trulance (plecanatide) for Chronic Idiopathic Constipation
19 January 2017 - Synergy Pharmaceuticals Announces Positive Results in First Phase 3 Trial of Plecanatide in Patients with Irritable Bowel Syndrome with Constipation (IBS-C)
9 December 2016 - Synergy Pharmaceuticals Provides Update on Ongoing FDA Review of Plecanatide CIC NDA and IBS-C Clinical Development Program
15 July 2016 - Synergy Pharmaceuticals Announces Acceptance of NDA for Plecanatide, a Novel Uroguanylin Analog, in Chronic Idiopathic Constipation
19 April 2016 - Synergy Pharmaceuticals Files NDA for Plecanatide in Chronic Idiopathic Constipation
29 January 2016
Drugs Associated with Synergy Pharmaceuticals Inc.
Synergy Pharmaceuticals Inc. manufactures, markets and/or distributes 1 drug in the United States. Medications listed here may also be marketed under different names in different countries. Non-US country and region specific information is not available on this page.
| Brand/Generic Name | Reviews | Rating |
|---|---|---|
|
Trulance
Generic name: plecanatide Drug class: guanylate cyclase-C agonists |
250 reviews | 6.0 / 10 |
| For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). | ||
